Tumour Marker Panel — Women

A blood panel measuring four tumour markers relevant to women, intended as a screening adjunct rather than a diagnostic test on its own. For 160 zł it covers CA 19-9, CEA, CA 15-3 and CA 125. It may be chosen by people wanting these markers checked as part of broader monitoring or because of family history. Tumour-marker results are non-specific and are always interpreted by a physician alongside other findings.

The Tumour Marker Panel for women measures four blood markers — CA 19-9, CEA (carcinoembryonic antigen), CA 15-3 and CA 125 — that are sometimes used as adjuncts in monitoring and screening contexts, packaged at 160 zł. These markers are proteins that can be present at varying levels in the blood, and the panel offers a convenient way to have them measured together. It is important to understand what such a panel is and is not: tumour markers are non-specific, can be affected by benign conditions, and a normal or raised result does not by itself confirm or exclude disease. For that reason the panel is positioned as a screening adjunct rather than a standalone diagnostic test, and results are always meant to be interpreted by a physician in the context of your history, symptoms, imaging and any other tests. People who choose it often do so as part of broader health monitoring, because of a relevant family history, or on the advice of a clinician who wants these values tracked over time. Blood is drawn at the al. Wyzwolenia 7 collection point during weekday-morning hours and analysed through Pramed's ALAB laboratoria partnership. The package can be purchased directly without a referral, but reviewing the results with one of the clinic's physicians is strongly recommended so that the numbers are understood correctly and any appropriate follow-up can be arranged.